Neoadjuvant pembrolizumab in localized/locally advanced solid tumors with mismatch repair deficiency

被引：12

作者：

Ludford, K. ^{[1
]}

Raghav, K. ^{[1
]}

Murphy, M. A. Blum ^{[1
]}

Fleming, N. D. ^{[2
]}

Nelson, D.

Lee, M. S. ^{[1
]}

Smaglo, B. G. ^{[1
]}

You, Y. N. ^{[3
]}

Tillman, M. M. ^{[4
]}

Kamiya-Matsuoka, C. ^{[5
]}

Thirumurthi, S. ^{[6
]}

Messick, C. ^{[4
]}

Johnson, B. ^{[1
]}

Vilar, E. ^{[7
]}

Thomas, J. ^{[1
]}

Foo, W. C. ^{[8
]}

Qiao, W. ^{[9
]}

Kopetz, S. ^{[1
]}

Overman, M. J. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Colon & Rectal Surg, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Surg Oncol, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Neuro Oncol, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA

[7] Univ Texas MD Anderson Canc Ctr, Clin Canc Prevent, Houston, TX 77030 USA

[8] Univ Texas MD Anderson Canc Ctr, Pathol Anat, Houston, TX 77030 USA

[9] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX 77030 USA

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.1703

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1758O

引用

页码：S1210 / S1210

页数：1

共 50 条

[21] The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
Wu Yunlong
Liu Tongtong
Zeng Hua
CANCER MEDICINE, 2023, 12 (03): : 2440 - 2452
[22] Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/ mismatch repair-deficient solid tumors
Li, Jian
Xu, Ye
Zang, Aimin
Gao, Yunong
Gao, Quanli
Zhang, Yanqiao
Wang, Dong
Xu, Jianming
Yuan, Ying
Jiang, Haiping
Ying, Jieer
Shi, Chunmei
Deng, Yanhong
Wang, Jing
Liu, Tianshu
Huang, Yi
Qian, Xiaoping
Pan, Yueyin
Cheng, Ying
Hu, Sheng
Wang, Jin
Shi, Mengyue
Wang, Ke
Hu, Han
Shen, Lin
CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (03)
[23] Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors
Jian Li
Ye Xu
Aimin Zang
Yunong Gao
Quanli Gao
Yanqiao Zhang
Dong Wang
Jianming Xu
Ying Yuan
Haiping Jiang
Jieer Ying
Chunmei Shi
Yanhong Deng
Jing Wang
Tianshu Liu
Yi Huang
Xiaoping Qian
Yueyin Pan
Ying Cheng
Sheng Hu
Jin Wang
Mengyue Shi
Ke Wang
Han Hu
Lin Shen
ChineseJournalofCancerResearch, 2024, 36 (03) : 257 - 276
[24] APC mutations in colorectal tumors with mismatch repair deficiency
Huang, J
Papadopoulos, N
McKinley, AJ
Farrington, SM
Curtis, LJ
Wyllie, AH
Zheng, S
Willson, JKV
Markowitz, SD
Morin, P
Kinzler, KW
Vogelstein, B
Dunlop, MG
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) : 9049 - 9054
[25] OLAPARIB PLUS PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED SOLID TUMORS WITH HOMOLOGOUS RECOMBINATION REPAIR MUTATION AND/OR HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY: KEYLYNK-007
Yap, Timothy A.
Dhawan, Mallika
Hendifar, Andrew E.
Maio, Michele
Owonikoko, Taofeek K.
Quintela-Fandino, Miguel
Shapira-Frommer, Ronnie
Saraf, Sanatan
Qiu, Ping
Jin, Fan
Gozman, Alexander
Levine, Douglas A.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A195 - A196
[26] A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy
Cox, Ronald E., Jr.
Mahipal, Amit
Chakrabarti, Sakti
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
[27] Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors
Seshadri, Ramakrishnan A.
Rajendranath, Rejiv
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (04) : 267 - 271
[28] The prognostic and predictive value of mismatch repair status in patients with locally advanced rectal cancer following neoadjuvant therapy
Wu, Zehua
Hu, Huabin
Wang, Chao
Zhang, Jianwei
Cai, Yue
Xie, Xiaoyu
Huang, Yan
Deng, Yanhong
ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (08)
[29] Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis
Wu, Xiaohua
Mao, Yimin
Xu, Nong
Bai, Yuxian
Wang, Dong
Chen, Xiaojun
Yin, Xianli
Deng, Yanhong
Yang, Jianwei
Zhang, Jieqing
Tang, Jie
Huang, Yi
Li, Jiayi
Luo, Suxia
Zheng, Hong
Zhao, Weidong
Xu, Miaomiao
Li, Nan
Mao, Yixiang
Gozman, Alexander
Xu, Jianming
ADVANCES IN THERAPY, 2025, : 2480 - 2489
[30] KEYNOTE-158: Final analysis of pembrolizumab in patients of Chinese descent with microsatellite instability-high/mismatch repair deficient advanced solid tumors
Xu, Jianming
Mao, Yimin
Xu, Nong
Bai, Yuxian
Wang, Dong
Chen, Xiaojun
Yin, Xianli
Deng, Yanhong
Yang, Jianwei
Zhang, Jieqing
Tang, Jie
Huang, Yi
Li, Jiayi
Luo, Suxia
Xu, Miaomiao
Li, Nan
Mao, Yixiang
Gozman, Alexander
Wu, Xiaohua
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →